ask="N/A"
ask_size="N/A"
average_daily_volume="141618"
bid="N/A"
bid_size="N/A"
book_value="3.29"
change="N/A"
change_from_200_day_moving_average="-3.96"
change_from_50_day_moving_average="0.43"
change_from_52_week_high="-11.75"
change_From_52_week_low="1.45"
change_in_percent="N/A"
close="5.95"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.54"
ebitda="-19.44M"
eps_estimate_current_year="-2.81"
eps_estimate_next_quarter="-0.90"
eps_estimate_next_year="-2.84"
ex_dividend_date="N/A"
float_shares="5820000"
high="N/A"
high_52_weeks="17.70"
last_trade_date="2/13/2017"
last_trade_price="5.95"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="4.50"
market_capitalization="46.51M"
moving_average_200_day="9.91"
moving_average_50_day="5.52"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.85"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-39.96%"
percent_change_from_50_day_moving_average="+7.71%"
percent_change_from_52_week_high="-66.38%"
percent_change_from_52_week_low="+32.22%"
previous_close="5.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.81"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="2.40"
stock_exchange="NCM"
symbol="TRIL"
volume="0"
weeks_range_52="4.50 - 17.70"
